Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Jaguar Health Inc (NASDAQ: JAGX) closed the day trading at $0.17 down -6.61% from the previous closing price of $0.18. In other words, the price has decreased by -$6.61 from its previous closing price. On the day, 38.88 million shares were traded. JAGX stock price reached its highest trading level at $0.1732 during the session, while it also had its lowest trading level at $0.1522.
Ratios:
For a better understanding of JAGX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.34 and its Current Ratio is at 2.00. In the meantime, Its Debt-to-Equity ratio is 7.48 whereas as Long-Term Debt/Eq ratio is at 6.43.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 07, 2021, initiated with a Overweight rating and assigned the stock a target price of $5.
On July 11, 2017, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $2.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JAGX now has a Market Capitalization of 48253632 and an Enterprise Value of 80252304. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.75 while its Price-to-Book (P/B) ratio in mrq is 2.48. Its current Enterprise Value per Revenue stands at 8.222 whereas that against EBITDA is -2.515.
Stock Price History:
Over the past 52 weeks, JAGX has reached a high of $1.22, while it has fallen to a 52-week low of $0.05. The 50-Day Moving Average of the stock is 87.76%, while the 200-Day Moving Average is calculated to be -36.47%.
Shares Statistics:
Over the past 3-months, JAGX traded about 60.60M shares per day on average, while over the past 10 days, JAGX traded about 134102140 shares per day. A total of 276.22M shares are outstanding, with a floating share count of 262.69M. Insiders hold about 4.90% of the company’s shares, while institutions hold 0.45% stake in the company. Shares short for JAGX as of 1711584000 were 19706188 with a Short Ratio of 0.33, compared to 1709164800 on 4890223. Therefore, it implies a Short% of Shares Outstanding of 19706188 and a Short% of Float of 8.5.
Earnings Estimates
On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$9. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
1 analysts predict $2.3M in revenue for the current quarter. It ranges from a high estimate of $2.61M to a low estimate of $2.61M. As of the current estimate, Jaguar Health Inc’s year-ago sales were $3.26MFor the next quarter, 1 analysts are estimating revenue of $2.76M. There is a high estimate of $2.76M for the next quarter, whereas the lowest estimate is $2.76M.
A total of 1 analysts have provided revenue estimates for JAGX’s current fiscal year. The highest revenue estimate was $9.32M, while the lowest revenue estimate was $9.32M, resulting in an average revenue estimate of $9.76M. In the same quarter a year ago, actual revenue was $11.96MBased on 1 analysts’ estimates, the company’s revenue will be $13.81M in the next fiscal year. The high estimate is $13.81M and the low estimate is $13.81M.
